Parlem Financial Statements From 2010 to 2026
| 4HW Stock | EUR 2.64 0.10 3.65% |
Check Parlem Telecom financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Parlem Telecom's main balance sheet or income statement drivers, such as , as well as many indicators such as . Parlem financial statements analysis is a perfect complement when working with Parlem Telecom Valuation or Volatility modules.
Parlem |
Parlem Telecom Companyia Company Current Valuation Analysis
Parlem Telecom's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Parlem Telecom Current Valuation | 130.25 M |
Most of Parlem Telecom's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Parlem Telecom Companyia is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Parlem Telecom Companyia has a Current Valuation of 130.25 M. This is 99.09% lower than that of the Healthcare sector and 97.2% lower than that of the Biotechnology industry. The current valuation for all Germany stocks is 99.22% higher than that of the company.
Parlem Telecom ia Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Parlem Telecom's current stock value. Our valuation model uses many indicators to compare Parlem Telecom value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Parlem Telecom competition to find correlations between indicators driving Parlem Telecom's intrinsic value. More Info.Parlem Telecom Companyia is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Parlem Telecom's earnings, one of the primary drivers of an investment's value.About Parlem Telecom Financial Statements
Parlem Telecom stakeholders use historical fundamental indicators, such as Parlem Telecom's revenue or net income, to determine how well the company is positioned to perform in the future. Although Parlem Telecom investors may analyze each financial statement separately, they are all interrelated. For example, changes in Parlem Telecom's assets and liabilities are reflected in the revenues and expenses on Parlem Telecom's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Parlem Telecom Companyia. Please read more on our technical analysis and fundamental analysis pages.
MolMed S.p.A., a medical biotechnology company, focuses on the research, development, and clinical validation of anticancer therapies. MolMed S.p.A. was founded in 1996 and is headquartered in Milan, Italy. MOLECULAR MED operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Parlem Stock
Parlem Telecom financial ratios help investors to determine whether Parlem Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Parlem with respect to the benefits of owning Parlem Telecom security.